Centre Hospitalier Universitaire De La Reunion

The medical center is at the forefront of research in systemic lupus erythematosus, focusing on innovative therapies to reduce disease activity and improve patient outcomes.

• Effectiveness of Cenerimod
• Long-term Safety and Tolerability

Through rigorous clinical trials, the center is advancing the understanding of lupus management, offering hope for improved quality of life for patients.

Specializing in peripheral T-cell lymphoma and anaplastic large cell lymphoma, the center is pioneering treatments that aim to enhance progression-free survival and response rates.

• Autologous Stem Cell Transplantation
• Nivolumab for Relapsed/Refractory Cases

These studies are crucial in developing personalized treatment strategies that improve patient prognosis and survival rates.

The center is dedicated to improving outcomes for patients with high-risk osteosarcoma through innovative treatment combinations.

• Mifamurtide with Chemotherapy

By integrating new therapeutic agents, the center aims to enhance event-free survival and reduce relapse rates in affected individuals.

Focusing on pediatric renal transplantation, the center is optimizing anticoagulation therapy to prevent vascular complications.

• Enoxaparin Dose Adjustment

This research is pivotal in ensuring the long-term success of transplants and improving patient safety.

In the field of early syphilis treatment, the center is evaluating alternative antibiotic regimens to enhance cure rates.

• Doxycycline vs. BPG

These efforts are aimed at providing more accessible and effective treatment options for patients worldwide.

Addressing breast cancer in young women, the center is exploring fertility preservation techniques alongside cancer treatment.

• Oocyte/Embryo Cryopreservation

This research is vital for maintaining reproductive health and quality of life for young cancer survivors.

The center is investigating treatments for neuroendocrine cells hyperplasia of infancy to improve respiratory outcomes.

• Methylprednisolone Pulses

These studies are essential for developing effective therapies for this rare pediatric condition.

Focusing on retinoblastoma, the center is advancing conservative treatment strategies to preserve vision and control disease.

• Intra-arterial Chemotherapy
• Adjuvant Treatment Post-Enucleation

These efforts are crucial in improving visual outcomes and survival rates in affected children.

In the realm of cervical cancer, the center is evaluating the efficacy of induction chemotherapy to enhance survival rates.

• Concurrent Chemoradiotherapy

This research is pivotal in refining treatment protocols for advanced cases, aiming to improve patient outcomes.

Specializing in prostate cancer with high-risk features, the center is exploring advanced therapeutic combinations to prevent relapse.

• Darolutamide and Radiotherapy

These studies are instrumental in developing comprehensive treatment plans that enhance metastasis-free survival.

The center is at the forefront of research in vitiligo, focusing on novel therapies to promote skin repigmentation.

• SCENESSE® and NB-UVB Light Therapy

This research is essential in providing effective treatment options for individuals affected by this condition.

In the field of metastatic renal cell carcinoma, the center is optimizing treatment regimens to improve survival outcomes.

• Immune Checkpoint Inhibitors
• VEGFR-Tyrosine Kinase Inhibitors

These efforts are crucial in advancing personalized medicine approaches for this challenging cancer type.

Focusing on cardiac failure post-myocardial infarction, the center is evaluating therapies to improve cardiac function and remodeling.

• Dapagliflozin Efficacy

This research is vital in enhancing recovery and quality of life for patients with heart failure.

Specializing in ependymoma, the center is advancing diagnostic and treatment strategies to improve patient outcomes.

• Centralized MRI Review
• Post-Operative Chemotherapy

These studies are essential in refining therapeutic approaches for this complex brain tumor.

In the realm of non-small cell lung cancer, the center is exploring combination therapies to enhance treatment efficacy.

• Platinum-Pemetrexed-Atezolizumab

This research is pivotal in developing targeted therapies for patients with specific genetic mutations.

The center is investigating treatments for obesity related to genetic variants, focusing on weight management and metabolic health.

• Setmelanotide Efficacy

This research is crucial in providing effective interventions for individuals with genetic predispositions to obesity.

Specializing in subarachnoid hemorrhage, the center is evaluating therapies to prevent cerebral ischemia and improve recovery.

• Milrinone Optimization

This research is vital in enhancing outcomes for patients with severe brain hemorrhages.

The center is advancing strategies for respiratory distress management, focusing on optimizing emergency interventions.

• Tracheal Intubation Optimization

This research is essential in improving patient safety and outcomes during critical care situations.

Focusing on acute promyelocytic leukemia in children and adolescents, the center is exploring combination therapies to enhance survival rates.

• ATO and ATRA Combination

This research is crucial in developing effective treatment protocols for young patients with this aggressive leukemia.